Biotechnology in Germany

Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Germany biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key Highlights

– The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.

– The German biotechnology industry had total revenues of $8.7bn in 2016, representing a compound annual growth rate (CAGR) of 7% between 2012 and 2016.

– The medical/healthcare segment was the industry's most lucrative in 2016, with total revenues of $4.3bn, equivalent to 49.7% of the industry's overall value.

– The German biotechnology industry will increase over the next five years, overtaking the UK as the top industry in Europe.

Scope

– Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Germany

– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Germany

– Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

– Add weight to presentations and pitches by understanding the future growth prospects of the Germany biotechnology market with five year forecasts

Reasons to buy

- What was the size of the Germany biotechnology market by value in 2016?

- What will be the size of the Germany biotechnology market in 2021?

- What factors are affecting the strength of competition in the Germany biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up Germany's biotechnology market?

Companies mentioned

Boehringer Ingelheim GmbH

Merck & Co., Inc.

MorphoSys AG

Table of Contents

Table of Contents

Executive Summary

Market value

Market value forecast

Category segmentation

Geography segmentation

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Category segmentation

Geography segmentation

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

Boehringer Ingelheim GmbH

Merck & Co., Inc.

MorphoSys AG

Macroeconomic Indicators

Country data

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine

List of Tables

List of Tables

Table 1: Germany biotechnology industry value: $ billion, 2012-16

Table 2: Germany biotechnology industry category segmentation: $ billion, 2016

Table 3: Germany biotechnology industry geography segmentation: $ billion, 2016

Table 4: Germany biotechnology industry value forecast: $ billion, 2016-21

Table 5: Boehringer Ingelheim GmbH: key facts

Table 6: Boehringer Ingelheim GmbH: key financials ($)

Table 7: Boehringer Ingelheim GmbH: key financials (€)

Table 8: Boehringer Ingelheim GmbH: key financial ratios

Table 9: Merck & Co., Inc.: key facts

Table 10: Merck & Co., Inc.: key financials ($)

Table 11: Merck & Co., Inc.: key financial ratios

Table 12: MorphoSys AG: key facts

Table 13: MorphoSys AG: key financials ($)

Table 14: MorphoSys AG: key financials (€)

Table 15: MorphoSys AG: key financial ratios

Table 16: Germany size of population (million), 2012-16

Table 17: Germany gdp (constant 2005 prices, $ billion), 2012-16

Table 18: Germany gdp (current prices, $ billion), 2012-16

Table 19: Germany inflation, 2012-16

Table 20: Germany consumer price index (absolute), 2012-16

Table 21: Germany exchange rate, 2012-16

List of Figures

List of Figures

Figure 1: Germany biotechnology industry value: $ billion, 2012-16

Figure 2: Germany biotechnology industry category segmentation: % share, by value, 2016

Figure 3: Germany biotechnology industry geography segmentation: % share, by value, 2016

Figure 4: Germany biotechnology industry value forecast: $ billion, 2016-21

Figure 5: Forces driving competition in the biotechnology industry in Germany, 2016

Figure 6: Drivers of buyer power in the biotechnology industry in Germany, 2016

Figure 7: Drivers of supplier power in the biotechnology industry in Germany, 2016

Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Germany, 2016

Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Germany, 2016

Figure 10: Drivers of degree of rivalry in the biotechnology industry in Germany, 2016

Figure 11: Boehringer Ingelheim GmbH: revenues & profitability

Figure 12: Boehringer Ingelheim GmbH: assets & liabilities

Figure 13: Merck & Co., Inc.: revenues & profitability

Figure 14: Merck & Co., Inc.: assets & liabilities

Figure 15: MorphoSys AG: revenues & profitability

Figure 16: MorphoSys AG: assets & liabilities

    Pricing

Quick Buy
Add to basket Request sample pages

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports